Sunimaps 25mg Tablet
By Sunimaps
Rx
7 Tablet in a Strip

Composition
Sunitinib(25mg)

Manufacturer - AMPS Biotech Pvt Ltd
36/22, Near Annapurna Building, J B Nagar, Andheri East, Mumbai City, Maharashtra, 400069

Expires on or after
July, 2025

liver
Sunimaps 25mg Tablet is considered safe for use in patients with liver disease. It is not necessary to adjust the dosage of this medication based on liver issues. It is important to adhere to the prescribed dosage and follow your healthcare provider's instructions while taking Sunimaps 25mg Tablet. If you have any concerns or experience any adverse effects related to liver function while using this medication, consult with your doctor promptly for proper guidance.

kidney
Sunimaps 25mg Tablet is safe for patients with kidney disease. No dose adjustment is necessary.

alcohol
Consult your doctor when consuming alcohol with Sunimaps 25mg Tablet.

driving
Caution – Driving Sunimaps 25mg Tablet may cause dizziness, affecting your ability to drive or operate machinery. Avoid driving if you experience this side effect while taking the medication.

pregnancy
Sunimaps 25mg Tablet may be unsafe to use during pregnancy. Limited human studies and animal studies show potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Caution is advised while breastfeeding and using Sunimaps 25mg Tablet as it may pass into breastmilk and potentially harm the baby. It is better to consult your doctor before using Sunimaps 25mg Tablet.
Habit Forming | No |
Chemical Class | Indole and Pyrrole Derivative |
Therapeutic Class | - |
Action Class | - |
₹1835
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025